Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Drugs for Treatment of Ulcerative Colitis in IBD01:29

Drugs for Treatment of Ulcerative Colitis in IBD

577
Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide...
577
Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists01:28

Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists

691
Neurokinin 1 (NK1) receptors are distributed across the GI tract, vagal afferents, and key CNS regions including the central vomiting center and chemoreceptor trigger zone (CTZ) Chemotherapy agents stimulate enterochromaffin cells in the gastrointestinal (GI) tract to release large amounts of substance P (SP). SP is a neuropeptide released by specific sensory nerves in response to many different stressors, including those in the GI mucosa affected by chemotherapy.  SP binds and activates...
691
NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

10.1K
The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
10.1K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

9.0K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
9.0K
Structure-Activity Relationships and Drug Design01:28

Structure-Activity Relationships and Drug Design

1.9K
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
1.9K
Abnormal Proliferation02:23

Abnormal Proliferation

5.3K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.3K

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Electrochemical synthesis of 2-oxa-bicyclo[2.1.1]hexanes by anodic oxidation-cyclization relay strategy.

Chemical science·2026
Same author

A consensus roadmap for post-traumatic epilepsy: Clinical biomarkers, research priorities, policy barriers, and pathways to interventional trials.

Epilepsia·2026
Same author

Heparinised saline versus normal saline flushing in maintaining arterial catheter patency in intensive care patients: A systematic review and meta-analysis of randomised controlled trials.

Australian critical care : official journal of the Confederation of Australian Critical Care Nurses·2026
Same author

Prehospital diagnosis and management of supraventricular tachycardia - a scoping review.

Scandinavian journal of trauma, resuscitation and emergency medicine·2026
Same author

Erratum to "Edaravone: Advances on cytoprotective effects, pharmacological properties, and mechanisms of action" [Pharmacological Reviews 78 (2025) 100101].

Pharmacological reviews·2026
Same author

Systemic inflammation and its associations in acute moderate-severe Traumatic Brain Injury: a cross-sectional study.

Brain, behavior, & immunity - health·2026

相关实验视频

Updated: Feb 28, 2026

Synthesis and Characterization of an Aspirin-fumarate Prodrug that Inhibits NFκB Activity and Breast Cancer Stem Cells
13:38

Synthesis and Characterization of an Aspirin-fumarate Prodrug that Inhibits NFκB Activity and Breast Cancer Stem Cells

Published on: January 18, 2017

12.7K

基于Ru的NSAID作为潜在的抗癌疗法

Silvia Bordoni1, Magda Monari2, Carla Boga1

  • 1Department of Industrial Chemistry 'Toso Montanari', Alma Mater Studiorum, Università di Bologna, Via Piero Gobetti, 85, 40129 Bologna, Italy.

Molecules (Basel, Switzerland)
|February 27, 2026
PubMed
概括

使用非类固醇抗炎药物 (NSAIDs) 作为配体合成了新型的复合物. 一种NSAID-复合物对癌细胞表现出显著的抗增殖作用,突出显示了新型金属治疗药物的潜力.

关键词:
这就是SCXRD.癌症 癌症 癌症 癌症 癌症金属制成品 - - 金属制成品鲁是的元素之一.

更多相关视频

Author Spotlight: Exploring the Role of Inflammation in the Co-occurrence of Primary Sjogren's Syndrome and Lung Adenocarcinoma
10:21

Author Spotlight: Exploring the Role of Inflammation in the Co-occurrence of Primary Sjogren's Syndrome and Lung Adenocarcinoma

Published on: September 20, 2024

931
Synthesis of a Borylated Ibuprofen Derivative Through Suzuki Cross-Coupling and Alkene Boracarboxylation Reactions
08:56

Synthesis of a Borylated Ibuprofen Derivative Through Suzuki Cross-Coupling and Alkene Boracarboxylation Reactions

Published on: November 30, 2022

3.5K

相关实验视频

Last Updated: Feb 28, 2026

Synthesis and Characterization of an Aspirin-fumarate Prodrug that Inhibits NFκB Activity and Breast Cancer Stem Cells
13:38

Synthesis and Characterization of an Aspirin-fumarate Prodrug that Inhibits NFκB Activity and Breast Cancer Stem Cells

Published on: January 18, 2017

12.7K
Author Spotlight: Exploring the Role of Inflammation in the Co-occurrence of Primary Sjogren's Syndrome and Lung Adenocarcinoma
10:21

Author Spotlight: Exploring the Role of Inflammation in the Co-occurrence of Primary Sjogren's Syndrome and Lung Adenocarcinoma

Published on: September 20, 2024

931
Synthesis of a Borylated Ibuprofen Derivative Through Suzuki Cross-Coupling and Alkene Boracarboxylation Reactions
08:56

Synthesis of a Borylated Ibuprofen Derivative Through Suzuki Cross-Coupling and Alkene Boracarboxylation Reactions

Published on: November 30, 2022

3.5K

科学领域:

  • 无机化学 无机化学
  • 药用化学 医学化学
  • 材料科学 材料科学 材料科学

背景情况:

  • 基于金属的药物通过将现有药物作为配体结合而提供增强的生物活性.
  • 鲁复合物被用于治疗应用,特别是在瘤学中.

研究的目的:

  • 合成使用非类固醇抗炎药物 (NSAIDs) 作为配体的新型鲁丁 (II) 复合物.
  • 研究这些新型金属制剂的结构和初步生物特性.

主要方法:

  • 通过[Ru(H) 2 ((CO) ((PPh3) 3中的配体的替代合成中性 κ2-(O,O) - 酸复合物.
  • 使用单晶X射线衍射 (SCXRD) 对选定的复合体进行表征.
  • 对抗癌症细胞系的抗增殖活性进行初步生物评估.

主要成果:

  • 成功合成了五种新型的-NSAID复合物,释放了分子.
  • 与迪克洛芬雅克和阿司匹林的复合物在结构上具有SCXRD的特征.
  • - 盐酸复合物 (2) 对HeLa癌细胞表现出有前途的抗增殖活性.

结论:

  • 无抗药- (NSAID-ruthenium) 复合物代表了开发新型抗癌金属治疗药物的可行平台.
  • 合成的复合物显示出在药物发现和开发中进一步调查的潜力.
  • 包含NSAIDs的鲁复合物需要进一步研究它们的治疗应用.